Journal
ADVANCED MATERIALS
Volume 25, Issue 33, Pages 4641-4645Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.201301917
Keywords
siRNA; drug delivery; nanoparticle; gene knockdown; aminoglycoside
Categories
Funding
- Alnylam Pharmaceuticals, Inc.
- NIH [EB000244, 1-RO1-CA132091-03]
- Damon Runyon Cancer Research Foundation (DFS) [2050-10]